These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 978406)

  • 1. Synthesis of potential mescaline antagonists.
    DeSantis F; Nieforth KA
    J Pharm Sci; 1976 Oct; 65(10):1479-84. PubMed ID: 978406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained analogs of mescaline.
    Wolters RJ; Bej AJ; Tanner NS
    J Pharm Sci; 1974 Sep; 63(9):1379-82. PubMed ID: 4427260
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and action on the central nervous system of mescaline analogues containing piperazine or homopiperazine rings.
    Majchrzak MW; Kotełko A; Guryn R; Lambert JB; Szadowska A; Kowalczyk K
    J Pharm Sci; 1983 Mar; 72(3):304-6. PubMed ID: 6682439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Hydroxydopamine inhibits some effects of mescaline centrally administered to rabbits.
    Ferri S; Reina RA; Braga P
    Psychopharmacology (Berl); 1977 Dec; 55(2):147-9. PubMed ID: 414273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mescaline and related compounds.
    Patel AR
    Fortschr Arzneimittelforsch; 1968; 11():11-47. PubMed ID: 4873202
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice.
    Shah NS; Hudnall SD; May D; Eargle D; Yates J
    Biol Psychiatry; 1979 Aug; 14(4):587-94. PubMed ID: 486615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors.
    Trulson ME; Crisp T; Henderson LJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):151-4. PubMed ID: 6581976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur analogues of psychotomimetic agents. Monothio analogues of mescaline and isomescaline.
    Jacob P; Shulgin AT
    J Med Chem; 1981 Nov; 24(11):1348-53. PubMed ID: 7310812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of mescaline HCl on behavior, resistance, and endocrine function of male mice.
    Sackler AM; Weltman AS; Johnson L
    Exp Med Surg; 1971; 29(1):118-27. PubMed ID: 5147592
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of a tricyclic mescaline analogue by catalytic C-H bond activation.
    Ahrendt KA; Bergman RG; Ellman JA
    Org Lett; 2003 Apr; 5(8):1301-3. PubMed ID: 12688744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).
    Dyer DC; Benington F; Morin RD
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):197-200. PubMed ID: 127560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mescaline and its derivative N-[3,4,5-trimethoxyphenylethyl]-aziridine on the spatial orientation of rats in a T-maze.
    Koupilová M; Herink J
    Physiol Bohemoslov; 1989; 38(6):497-502. PubMed ID: 2534189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 15. Conformationally constrained analogs of mescaline II.
    Wolters RJ; Bej AJ; Tanner NS
    J Pharm Sci; 1975 Dec; 64(12):2013-4. PubMed ID: 1206499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity and gross behavioral effects of amphetamine, four methoxyamphetamines, and mescaline in rodents, dogs, and monkeys.
    Davis WM; Bedford JA; Buelke JL; Guinn MM; Hatoum HT; Waters IW; Wilson MC; Braude MC
    Toxicol Appl Pharmacol; 1978 Jul; 45(1):49-62. PubMed ID: 99845
    [No Abstract]   [Full Text] [Related]  

  • 17. C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor.
    McLean TH; Chambers JJ; Parrish JC; Braden MR; Marona-Lewicka D; Kurrasch-Orbaugh D; Nichols DE
    J Med Chem; 2006 Jul; 49(14):4269-74. PubMed ID: 16821786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues.
    Nichols DE; Dyer DC
    J Med Chem; 1977 Feb; 20(2):299-301. PubMed ID: 836502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
    Lautar SL; Rojas C; Slusher BS; Wozniak KM; Wu Y; Thomas AG; Waldon D; Li W; Ferraris D; Belyakov S
    Brain Res; 2005 Jun; 1048(1-2):177-84. PubMed ID: 15925329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic blocking agents as potent antagonists of mescaline-induced contractions in the rat uterus.
    Jaques R
    Experientia; 1976 Aug; 32(8):1038-9. PubMed ID: 8329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.